38 employees
OliX is a clinical stage biotechnology company.
2010
$37M
from 4 investors over 4 rounds
OliX Pharmaceuticals, Inc. raised $37M on December 1, 2020
Investors: Kiwoom Investment, NH Investment & Securities, IMM Investment Corp. and AJU IB INVESTMENT